View My Shopping Cart

Managed Care Contracts & Payer Reimbursement

E-Briefings in this category:

Changes in Healthcare Costs during the Obama Administration: What Happened to Spending by Businesses and Consumers

Noted Clinical Laboratory and Anatomic Pathology Legal Experts Jane Pine Wood and Richard Cooper to Address 2017’s Important Changes in Legal, Compliance, and Managed Care Issues for Lab Industry

Good News for Honest Clinical Laboratories: Federal Fraud Case in New Jersey Brings More Convictions and Indictments of Doctors Who Accepted Illegal Inducements

CMS Issues PAMA Final Rule That Aims to Cut Medicare’s Clinical Laboratory Test Price Schedule Sharply Beginning in 2018

How the ACA and Medicaid Expansion Are Affecting Patient Bad Debt at Hospitals, Pathology Groups, and Clinical Laboratories

Nearly One-Third of Traditional Medicare Payments Now Based on Value-Based Reimbursement and Alternative Payment Models

CMS Notifies Theranos of CLIA Sanctions That Include Revoking Clinical Laboratory’s CLIA License and a Two-Year Ban on Holmes, Balwani, and Dhawan

CMS Says Obamacare Premiums to Increase by an Average of 7.5% in 2016, But Squeeze on Consumers’ Wallets Will Vary Depending on Where They Live

ONC Releases Final Rule for Stage 3 Meaningful Use: What Most Affects Clinical Laboratories and Anatomic Pathology Groups

‘10 Disruptive Forces in Healthcare’ Provide Challenges for Clinical Laboratories and Pathology Groups Forced to Respond to a Changing Marketplace

Digital-Era Millennials Using New Tools to Select Doctors, Stay Informed, and Shop for Care, Including Selecting Clinical Pathology Laboratories

Walmart Health Plan Praised as Affordable, Superior Option to Obamacare Exchange Coverage While Offering Expanded Provider Networks

Experts Say Medicare Accountable Care Organizations (ACOs) Produced Mixed Results in 2014 Even as Enrollment Continues to Grow Significantly

Congress Takes Aim at Healthcare Technology Data Blocking in a Move That Might Benefit Many Clinical Pathology Laboratories

Clinical Pathology Labs Take Note: Death March for Fee-For-Service Payment Model Continues as Support for Change Gathers Steam

Healthcare Strategist Predicts that Skyrocketing Costs of Cancer Care May Soon Exceed the Value of New Medical Laboratory Tests and Therapeutic Drugs for Cancer

Health Diagnostic Laboratory Puts Itself Up for Sale as Virginia Medical Lab Company Solicits Bids for Auction

Creating Added Value from Clinical Pathology Laboratory Testing Produced Improved Outcomes at University of Mississippi Medical Center and Broward Health

Some Accountable Care Organizations Are Showing Improved Patient Outcomes and Lower Costs: Still Unclear How Payment Will Be Made for Clinical Laboratory Tests

Speakers from UCLA, Alverno Clinical Laboratories, and TriCore Reference Labs Discuss the Creation of Value-Added Lab Services at 20th Annual Executive War College

Attention Pathologists! MD Anderson and UnitedHealthcare Ink Bundled Payment Agreement for Cancer Care

JAMA Report Highlights Inaccuracies in Pathologists’ Breast Cancer Diagnoses

Most Clinical Laboratories and Pathology Groups Unprepared to Help Client Physicians Meet Meaningful Use Stage 2 Criteria

Does Your Clinical Laboratory or Pathology Group Have the Effective Leaders It Needs During These Challenging Times?

Understanding Today’s Trends in Healthcare and the Clinical Laboratory and Pathology Testing Marketplace

2014’s Healthcare Price Transparency Report Card Reveals Few States Are Making It Easy and Fast for Consumers to See the Prices Charged by Hospitals, Physicians, and Medical Laboratories

More Media Reports About How Health Insurers Are Reluctant to Reimburse for Genetic Tests, Thus Angering Many Patients and Causing Medical Laboratories to Go Unpaid

Castlight Health Offers Employers a Cloud-based Price Transparency Tool to Help Employees Shop for Low-Cost, High Quality Health Services

Certain Pathologists Found Themselves in the ‘Highest Paid’ Media Spotlight after Medicare Officials Published Physician Pay Data for 2012

New Federal Law Has Potential to Financially Devastate Local Clinical Laboratories, While Favoring Larger National Medical Labs

Copyright © 2017-2019 the Dark Intelligence Group, Inc. All rights reserved. Reproduction in whole or part without permission is prohibited. We Value Your Privacy! The Dark Intelligence Group will never sell, rent or otherwise abuse your email address. It will be used solely for the purpose of sending you the Dark Daily newsletter and updates about the Dark Daily. Should you wish to unsubscribe at any time, instructions are included with each email for immediate removal from the Dark Daily newsletter subscriber file.